Yawei Liu

Yawei Liu serves as an Associate Professor at the University of Copenhagen, affiliated with the Issazadeh-Navikas Group at the Biotech Research and Innovation Centre (BRIC). His research program bridges molecular immunology and neuroscience to investigate neurodegenerative disorders through the lens of immune regulation.

His core research domains include:

• Molecular and Cell Biology: Mechanistic studies of signaling pathways like PI3K/Akt and IFN-β in cellular differentiation
• Immunology: Specialization in T cell subsets including regulatory T cells (Tregs), invariant natural killer T cells, and Th1 cell fate determination
• Neuroimmunology: Exploration of neuron-immune crosstalk in Parkinson's disease dementia and multiple sclerosis

Analysis of his 2021-2024 publications reveals a concentrated focus on molecular drivers of neuroinflammation, particularly the roles of IFN-β signaling, FoxA1+ Treg generation, and costimulatory molecules like ADAM12 in neurodegenerative contexts. His work consistently integrates immunological mechanisms with neurological outcomes, emphasizing therapeutic targets for Parkinson's and multiple sclerosis.

Dr. Liu operates within the Issazadeh-Navikas Group at BRIC, a research unit dedicated to uncovering fundamental mechanisms in neuroinflammatory diseases through interdisciplinary approaches combining molecular biology, immunology, and neuroscience.